Prevalence, risk factors, and treatment of small intestinal bacterial overgrowth in children
Clinical and Experimental Pediatrics · 15.09.2023 · 66 (9) · 377-383
DOI: 10.3345/cep.2022.00969 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Pediatrics, erschienen am 15.09.2023. Verfasst von Yu Kyung Cho und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Small intestinal bacterial overgrowth (SIBO) is defined as the presence of an excessive number of bacteria within the small bowel. Pediatric SIBO is a heterogeneous disorder that manifests as various symptoms ranging from mild gastrointestinal symptoms to malabsorption or malnutrition. The carbohydrate breath test is a commonly used, safe, and noninvasive diagnostic test; however, a standardized methodology is lacking. Multiple factors, such as neuromuscular disorders, systemic diseases, chronic drug use, or altered intestinal anatomy that disturb intestinal motility or induce an abnormality in the body’s defense systems against intestinal bacteria, predispose children to SIBO. The high prevalence and similar symptoms of SIBO in functional gastrointestinal disorders, including irritable bowel syndrome, suggest an association between them. The principles of treatment include managing predisposing conditions, nutritional support, symptom control, and antibacterial treatment. Rifaximin is the most commonly used drug. To date, studies of antibiotic treatment in pediatric populations with irritable bowel syndrome or SIBO are lacking and have shown mixed results. Here we review the prevalence, diagnostic tests, and treatment results in pediatric populations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Department of Pediatrics, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Zitieren
APA
Cho, Y. K., Lee, J., & Paik, C. N. (2023). Prevalence, risk factors, and treatment of small intestinal bacterial overgrowth in children. Clinical and Experimental Pediatrics, 66(9), 377-383. https://doi.org/10.3345/cep.2022.00969
Vancouver
Cho YK, Lee J, Paik CN. Prevalence, risk factors, and treatment of small intestinal bacterial overgrowth in children. Clinical and Experimental Pediatrics. 2023;66(9):377-383. doi:10.3345/cep.2022.00969
BibTeX
@article{Cho2023,
author = {Cho, Yu Kyung and Lee, Jin and Paik, Chang Nyol},
title = {Prevalence, risk factors, and treatment of small intestinal bacterial overgrowth in children},
journal = {Clinical and Experimental Pediatrics},
year = {2023},
volume = {66},
number = {9},
pages = {377--383},
doi = {10.3345/cep.2022.00969}
}
EUVIMED